Insider Trading History of Lea Leiv

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lea Leiv since 2007. This trader's CIK number is 939012. At the time of last reporting, Lea Leiv was the Chief Financial Officer of Corvus Pharmaceuticals, Inc.. (stock ticker symbol CRVS). Also see all insider trading activities at Corvus Pharmaceuticals, Inc..

Note that in the past LEA LEIV also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmacyclics Inc (PCYC) by Lea Leiv

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 PCYC 5,000 $10,069 0 $0 0 $0

Yearly summary of insider trading at Corvus Pharmaceuticals, Inc. (CRVS) by Lea Leiv

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CRVS 49,038 $77,044 0 $0 0 $0
2019 CRVS 25,500 $88,980 0 $0 0 $0
2018 CRVS 24,700 $102,406 0 $0 0 $0


Insider trading activities at 2 companies by Lea Leiv:

1. Pharmacyclics Inc (PCYC)

2. Corvus Pharmaceuticals, Inc. (CRVS)

Table 1. Insider trading of Pharmacyclics Inc (PCYC) by Lea Leiv

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-08-22 PCYC Buy 3,000 2.01 6,029
2007-08-21 PCYC Buy 2,000 2.02 4,040

Table 2. Insider trading of Corvus Pharmaceuticals, Inc. (CRVS) by Lea Leiv

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-17 CRVS Buy 13,878 1.65 22,898
2022-03-16 CRVS Buy 35,160 1.54 54,146
2019-06-07 CRVS Buy 10,000 3.38 33,800
2019-06-06 CRVS Buy 15,500 3.56 55,180
2018-12-21 CRVS Buy 24,700 4.15 102,406

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lea Leiv (Chief Financial Officer of Corvus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.